Which of the following are extraglandular manifestations of Sjögren's syndrome: cutaneous purpuric vasculitis, xerostomia and xerophthalmia, parotid gland enlargement, glomerulonephritis, or interstitial nephritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Extraglandular Manifestations of Sjögren's Syndrome

The extraglandular manifestations among the options listed are: (a) cutaneous purpuric vasculitis, (d) glomerulonephritis, and (e) interstitial nephritis. Xerostomia, xerophthalmia, and parotid gland enlargement are glandular manifestations, not extraglandular.

Understanding the Classification

Sjögren's syndrome manifestations are divided into two distinct categories based on the tissue involvement:

Glandular Manifestations (NOT extraglandular):

  • Xerostomia (dry mouth) and xerophthalmia (dry eyes) result from lymphocytic infiltration of salivary and lacrimal glands 1
  • Parotid gland enlargement represents direct exocrine gland involvement 2
  • These are the defining features of the disease itself, not extraglandular complications

Extraglandular Manifestations (the correct answers):

The extraglandular features occur in 40-50% of patients and fall into two pathophysiologic categories 3, 4:

Category 1: Epithelial lymphocytic invasion

  • Interstitial nephritis - results from lymphocytic infiltration of renal epithelial tissues 3, 4
  • Lung involvement (interstitial pneumonitis)
  • Liver involvement

Category 2: Immune complex-mediated disease

  • Cutaneous purpuric vasculitis - leukocytoclastic or cryoglobulinemic vasculitis occurring in 5-10% of patients 5
  • Glomerulonephritis - immune complex deposition in glomeruli 3
  • Peripheral neuropathy
  • These manifestations are associated with cryoglobulins, low C4 levels, and carry worse prognosis with higher lymphoma risk 3, 4

Clinical Significance

Patients with vasculitis, glomerulonephritis, palpable purpura, low C4 levels, and cryoglobulinemia represent a high-risk subset with increased morbidity, mortality, and lymphoma development risk (approximately 5% overall lymphoma risk) 3, 4. These patients require aggressive immunosuppression, typically glucocorticoids combined with synthetic immunosuppressives (cyclophosphamide, azathioprine, methotrexate) or rituximab for refractory cases 6, 5.

Key Pitfall to Avoid:

Do not confuse the primary sicca symptoms (xerostomia/xerophthalmia) and salivary gland enlargement as "extraglandular." These are the core glandular features that define the disease. The term "extraglandular" specifically refers to involvement of organs and tissues outside the exocrine glands 7, 4.

References

Research

Mortality in Sjögren's syndrome.

Clinical and experimental rheumatology, 2008

Research

[Vasculopathy in Sjögren's syndrome].

Zeitschrift fur Rheumatologie, 2009

Research

Extraglandular manifestations of primary Sjögren's syndrome.

Oral and maxillofacial surgery clinics of North America, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.